Events
-
ENDO 2026: Women’s thyroid cancer risk may be linked to reproductive lifespan and hormone therapy
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
ASCO 2026: CAPTURE trial delivers learnings for metastatic breast cancer treatment
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
ASCO 2026: Lancet Commission predict shortfall of 100 million cancer care workers by 2050
-
-
ASCO 2026: Teclistamab extends survival, deepens remissions in relapsed multiple myeloma
-
-
-
Human uterus colonised by clones with cancer-driving mutations that arise early in life
Many cells in the inner lining of the uterus carry ‘cancer-driving’ mutations that frequently arise…
Nutrient deficiency in tumour cells attracts cells that suppress the immune system
Some solid tumours have a very high growth rate, which often leads to a lack…
New risk prediction model could identify those at higher risk of pancreatic cancer
A risk prediction model that combined genetic and clinical factors with circulating biomarkers identified people…
Addition of S-1 to post-operative endocrine therapy improves outcomes for patients with hormone receptor-positive, HER2-negative breast cancer
- Long-term follow-up shows oestrogen alone and oestrogen plus progestin have opposite effects on breast cancer incidence in postmenopausal women
- Neoadjuvant and adjuvant treatment with pembrolizumab improves pathologic complete response rates for patients with triple-negative breast cancer with lymph node involvement
- New test predicts chance of living more than a year on targeted breast cancer treatment
Caution urged on speculative panel testing for hereditary breast cancer
Researchers at Peter MacCallum Cancer Centre are calling for greater caution in genetic testing for familial breast cancer, warning of…
JOIN THE ONCOLOGY NETWORK
If you would like even more free news articles, access to our exclusive HCP only content including the latest podcasts from The Oncology Podcast and our Industry Partner Podcasts (including links to all papers and show notes), along with all our other resources, head over to The Oncology Network and sign up - FREE forever for HCPs only.